SaveHealth reports on 10 hypertension medications, their classifications, effectiveness, side effects, and safety in managing ...
Winrevair, also known as sotatercept-csrk, is a medicine used to treat pulmonary arterial hypertension (PAH), which causes high blood pressure in the arteries that go from your heart to your lungs.
In treatment-naïve patients with PAH, initial monotherapy improves exercise capacity, hemodynamics, and outcomes when compared with those noted among untreated patients. In patients who are newly ...
Nitric oxide (NO) is a key mediator of neural and haemodynamic effects. NO diffuses into vascular smooth muscle cells, stimulating the production of cGMP and leading to vasodilatation. The effects of ...
A 40-year-old woman who was a frequent traveler suddenly found herself struggling to breathe after taking just a few steps. What began as unexplained fatigue and shortness of breath quickly disrupted ...
Chronic thromboembolic pulmonary hypertension (CTPH) is associated with considerable morbidity and mortality. Its incidence after pulmonary embolism and associated risk factors are not well documented ...
In 2025, respiratory news highlighted advances in lung imaging, expanded support for pulmonary rehabilitation and promising ...
What is persistent pulmonary hypertension of the newborn? In short, PPHN is a serious breathing problem that affects very young babies. It usually affects babies born at full term or at 34 weeks or ...
Here are the top 5 most-read pulmonary fibrosis articles of 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback